Drug Shortage Report for CYMBALTA

Last updated on 2023-01-19 History
Report ID 181402
Drug Identification Number 02301490
Brand name CYMBALTA
Common or Proper name Duloxetine hydrochloride delayed release capsules
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) DULOXETINE
Strength(s) 60MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size Carton containing 28 capsules in blister packaging
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-01-18
Estimated end date 2023-02-15
Actual end date
Shortage status Actual shortage
Updated date 2023-01-19
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2023-01-19 English Compare
v2 2023-01-18 French Compare
v1 2023-01-18 English Compare

Showing 1 to 3 of 3